Status:
COMPLETED
Effects of EPA and Vitamin E on Leptin, Adiponectin and Enzymatic Antioxidants in Type 2 DM
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
30-55 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate efficacy and safety of EPA(Eicosapentaenoic Acid)alone and with VitE in diabetic patients.
Detailed Description
Randomized, double-blind, placebo-controlled, parallel-group study design After a 12weeks, subjects with type II DM will be randomized to receive either 2000 mg pearl EPA per day plus a double-blinded...
Eligibility Criteria
Inclusion
- DM Type II.
- Antidiabetic drug therapy which cannot be stopped.
- History of DM about 2-15 year.
- Age between 30-55 year.
- No History of circulatory, thyroid, pulmonary, liver, kidney, cancer.
Exclusion
- DM Type I.
- Nephropathy.
- Retinopathy.
- Cancer.
- Thyroid disease.
- Renal failure.
- pulmonary disease
- MI.
- CHD.
- Liver disease,
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT00817622
Start Date
January 1 2007
End Date
September 1 2009
Last Update
November 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tehran University Of Medical Sciences
Tehran, Tehran Province, Iran